##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 62 Download : 58

##plugins.themes.academic_pro.article.main##

Abstract

Epilepsy is a major public health problem. Several studies suggest a significant influence of epilepsy and its treatment on the dynamic and functional properties of brain activity. Epilepsy can affect mental development, cognition and behaviour. Patients with epilepsy may have reduced intelligence, attention and problems with memory, language and frontal executive functions.

Keywords

Cognition epilepsy mechanisms

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Sultonova Dilbar Azamat qizi., & Azizova R.B. (2023). Impact of Fixed and Dynamic Factors on Cognitive Ability in Epilepsy. Texas Journal of Medical Science, 27, 99–103. https://doi.org/10.62480/tjms.2023.vol27.pp99-103
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Annegers JF. The epidemiology of epilepsy. In: Wyllie E, editor. The treatment of epilepsy: Principles and practice. Baltimore, MD: Williams and Wilkins, 1996.
  2. Gulshirin, C. (2020). Pharmacoresistance in epilepsy and ways for overcoming it (literature review). Вестник Санкт-Петербургского университета. Медицина, 15(3), 184-197.
  3. Hamed SA. Leptin and insulin homeostasis in epilepsy: Relation to weight adverse conditions. Epilepsy Res 2007;75:1–9.
  4. Hamed SA, Hamed EA, Shokry M, Mohamed HO, Abdellah MM. The reproductive conditions and lipid profile in females with epilepsy. Acta Neurol Scand 2007;115:12–27.
  5. Elger CE, Helmstaedter C, Kurthen M. Chronic epilepsy and cognition. Lancet Neurol 2004;3:663–672.
  6. Hamed SA. Neuronal plasticity: Implications in epilepsy progression and management. Drug Dev Res 2007;68:498–511.
  7. Cormack F, Cross JH, Isaacs E, et al. The development of intellectual abilities in pediatric temporal lobe epilepsy. Epilepsia 2007;48:201–204.
  8. Shannon HE, Love PL. Effects of antiepileptic drugs on learning as assessed by a repeated acquisition of response sequences task in rats. Epilepsy Behav 2007;10:16–25.
  9. Sultonova, D. A., Azizova, R. B., Parpibayeva, D. A., & Musayeva, M. A. (2023). HIPPOCAMPAL SCLEROSIS: PATHOGENISIS AND IMAGING.
  10. Berg AT, Langfitt JT, Testa FM, Levy SR, DiMario F, Westerveld M, Kulas J. Global cognitive function in children with epilepsy: A community-based study. Epilepsia 2008;49:608–614.
  11. Gokcay A, Celebisoy N, Gokcay F, Atac C. Cognitive functions evaluated by P300 and visual and auditory number assays in children with childhood epilepsy with occipital paroxysms (CEOP). Seizure 2006;15:22–27.
  12. Briellmann RS, Wellard RM, Jackson GD.Seizure-associated abnormalities in epilepsy: Evidence from MR imaging. Epilepsia 2005;46:760–766.
  13. Rzezak P, Fuentes D, Guimara˜ es CA, et al. Frontal lobe dysfunction in children with temporal lobe epilepsy. Pediatr Neurol 2007;37:176–185.
  14. Азизова, Р. Б. (2022). Когнитивные расстройства при различных форм эпилепсии.
  15. Preve1йy ML, Delaney RC, Cramer JA, Mattson RH. Complex partial and secondarily generalized seizure patients: Cognitive functioning prior to treatment with antiepileptic medication VA epilepsy cooperative study 264 group. Epilepsy Res 1998;30:1–9.
  16. Titze K, Koch S, Helge H, Lehmkuhl U, Rauh H, Steinhausen HC. Prenatal and family risks of children born to mothers with epilepsy: Effects on cognitive development. Dev Med Child Neurol 2008;50:117–122.
  17. Dodrill C. Progressive cognitive decline in adolescents and adults with epilepsy. Prog Brain Res 2002;135:399–407.
  18. Hendriks MPH, Aldenkamp AP, Alpherts WCJ, Ellis J, Vermeulen J, van der Vlugt H. Relationships betweenepilepsy-related factors and memory impairment. Acta Neurol Scand 2004;110:291–300.
  19. Goode DJ, Penry JK, Dreifuss FE. Effects of paroxysmal spike-wave and continuous visual-motor performances. Epilepsia 1970;11:241–254.
  20. Binnie CD. Cognitive Impairment during epileptiform discharges: Is it ever justifiable to treat the EEG? Lancet Neurol 2003;2:725–730.
  21. Azizova, R. B. (2023). POTENTIAL BIOMARKER FOR EPILEPSY: HIGH-MOBILITY GROUP BOX 1 PROTEIN (HMGB1). Horizon: Journal of Humanity and Artificial Intelligence, 2(6), 47-52.
  22. Seidenberg M, Hermann B, Wyler AR, Davies K, Dohan FC Jr, Leveroni C. Neuropsychological outcome following anterior temporal lobectomy in patients with and without the syndrome of mesial temporal epilepsy. Neuropsychology 1998;12:303–305.